Nureca Ltd

₹ 274 0.07%

22 Nov - close price

About

Incorporated in 2016, Nureca Ltd is in the business of home healthcare and wellness products^[1]

Key Points

Business Overview:^[1]^[2]
NL is a D2C healthcare and wellness company with a USFDA, CE, FSSAI, and ISO 13485-certified product range of over 150 SKUs across different categories. It supports diagnosis, treatment, and prevention of illness through monitoring & analysis of health data.

Website BSE NSE

Market Cap ₹ 274 Cr.
Current Price ₹ 274
High / Low ₹ 469 / 240
Stock P/E
Book Value ₹ 193
Dividend Yield 0.00 %
ROCE -1.19 %
ROE -1.12 %
Face Value ₹ 10.0

Add ratio to table

Edit ratios

Pros

Company is almost debt free.

Cons

Company has low interest coverage ratio.
Company has a low return on equity of 5.98% over last 3 years.
Promoter holding has decreased over last 3 years: -6.23%

* The pros and cons are machine generated. Pros / cons are based on a checklist to highlight important points. Please exercise caution and do your own analysis.

Peer comparison

Sector: E-Commerce/App based Aggregator Industry: Trading

Edit Columns

Loading peers table ...

Detailed Comparison with:

Quarterly Results

Standalone Figures in Rs. Crores / View Consolidated

	Sep 2021	Dec 2021	Mar 2022	Jun 2022	Sep 2022	Dec 2022	Mar 2023	Jun 2023	Sep 2023	Dec 2023	Mar 2024	Jun 2024	Sep 2024
	46.91	48.08	41.08	26.06	36.79	27.84	21.22	21.23	31.35	22.37	19.56	23.31	32.37
	40.85	42.89	43.61	31.56	41.63	29.08	25.03	24.22	30.31	26.80	24.32	26.23	35.03
Operating Profit	6.06	5.19	-2.53	-5.50	-4.84	-1.24	-3.81	-2.99	1.04	-4.43	-4.76	-2.92	-2.66
OPM %	12.92%	10.79%	-6.16%	-21.11%	-13.16%	-4.45%	-17.95%	-14.08%	3.32%	-19.80%	-24.34%	-12.53%	-8.22%
	2.12	1.75	1.71	1.18	1.91	1.92	2.15	2.69	3.21	5.92	-1.25	5.82	3.21
Interest	0.12	0.11	0.28	0.13	0.10	0.10	0.10	0.11	0.08	0.10	0.17	0.13	0.25
Depreciation	0.30	0.41	0.57	0.59	0.60	0.58	0.54	0.56	0.56	0.56	0.56	0.61	0.57
Profit before tax	7.76	6.42	-1.67	-5.04	-3.63	0.00	-2.30	-0.97	3.61	0.83	-6.74	2.16	-0.27
Tax %	29.38%	24.77%	-29.94%	-23.21%	-23.14%		-21.74%	-22.68%	26.87%	90.36%	-34.57%	44.91%	140.74%
	5.49	4.84	-1.17	-3.87	-2.78	0.03	-1.80	-0.74	2.64	0.08	-4.41	1.20	-0.65
EPS in Rs	5.49	4.84	-1.17	-3.87	-2.78	0.03	-1.80	-0.74	2.64	0.08	-4.41	1.20	-0.65
Raw PDF

Profit & Loss

Standalone Figures in Rs. Crores / View Consolidated

	Mar 2017 5m	Mar 2018	Mar 2019	Mar 2020	Mar 2021	Mar 2022	Mar 2023	Mar 2024	TTM
	0.02	0.59	0.73	99.43	213.33	255.55	111.90	94.52	97.61
	0.02	0.57	0.70	89.72	151.65	199.78	127.04	105.18	112.38
Operating Profit	0.00	0.02	0.03	9.71	61.68	55.77	-15.14	-10.66	-14.77
OPM %	0.00%	3.39%	4.11%	9.77%	28.91%	21.82%	-13.53%	-11.28%	-15.13%
	0.00	0.00	0.00	0.06	2.82	7.72	6.91	10.09	13.70
Interest	0.00	0.00	0.00	0.77	1.60	0.73	0.43	0.46	0.65
Depreciation	0.00	0.00	0.00	0.37	0.41	1.43	2.30	2.24	2.30
Profit before tax	0.00	0.02	0.03	8.63	62.49	61.33	-10.96	-3.27	-4.02
Tax %		50.00%	33.33%	25.72%	25.54%	26.12%	-23.18%	-25.38%
	0.00	0.02	0.02	6.41	46.53	45.31	-8.42	-2.44	-3.78
EPS in Rs	0.00	20.00	20.00	6,410.00	46.53	45.31	-8.42	-2.44	-3.78
Dividend Payout %		0.00%	0.00%	0.00%	4.30%	6.62%	0.00%	0.00%

Compounded Sales Growth
10 Years:	%
5 Years:	165%
3 Years:	-24%
TTM:	-4%

Compounded Profit Growth
10 Years:	%
5 Years:	%
3 Years:	%
TTM:	-3008%

Stock Price CAGR
10 Years:	%
5 Years:	%
3 Years:	-43%
1 Year:	-23%

Return on Equity
10 Years:	%
5 Years:	13%
3 Years:	6%
Last Year:	-1%

Balance Sheet

Standalone Figures in Rs. Crores / View Consolidated

	Mar 2017	Mar 2018	Mar 2019	Mar 2020	Mar 2021	Mar 2022	Mar 2023	Mar 2024	Sep 2024
Equity Capital	0.01	0.01	0.01	0.01	10.00	10.00	10.00	10.00	10.00
Reserves	0.00	0.02	0.04	14.96	153.29	193.74	185.26	182.86	183.43
	0.00	0.00	0.00	9.70	3.81	4.33	3.25	2.43	4.34
	0.07	0.31	1.23	9.19	18.79	11.47	8.18	9.05	13.36
Total Liabilities	0.08	0.34	1.28	33.86	185.89	219.54	206.69	204.34	211.13
	0.00	0.00	0.06	1.06	3.37	9.78	8.08	6.33	8.27
CWIP	0.00	0.00	0.00	0.00	0.30	0.42	0.00	0.00	0.00
Investments	0.00	0.00	0.00	0.05	0.82	34.49	62.14	96.69	3.06
	0.08	0.34	1.22	32.75	181.40	174.85	136.47	101.32	199.80
Total Assets	0.08	0.34	1.28	33.86	185.89	219.54	206.69	204.34	211.13

Cash Flows

Standalone Figures in Rs. Crores / View Consolidated

	Mar 2017	Mar 2020	Mar 2021	Mar 2022	Mar 2023	Mar 2024
	-0.01	-7.85	35.10	1.83	12.05	-3.00
	0.00	-0.39	-110.48	-3.37	-18.30	17.84
	0.01	8.20	92.34	-7.30	-1.51	-1.28
Net Cash Flow	0.00	-0.05	16.96	-8.84	-7.76	13.56

Ratios

Standalone Figures in Rs. Crores / View Consolidated

	Mar 2017	Mar 2018	Mar 2019	Mar 2020	Mar 2021	Mar 2022	Mar 2023	Mar 2024
Debtor Days	365.00	86.61	65.00	47.35	0.39	4.10	13.93	6.99
Inventory Days	0.00	100.96	589.62	92.82	135.10	173.87	154.02	155.86
Days Payable		232.98	849.33	33.05	32.18	12.94	23.36	26.61
Cash Conversion Cycle	365.00	-45.41	-194.71	107.12	103.31	165.03	144.59	136.24
Working Capital Days	182.50	-12.37	-45.00	85.13	61.58	110.39	152.20	162.88
ROCE %		100.00%	75.00%	76.05%	66.84%	32.74%	-5.05%	-1.19%

Shareholding Pattern

Numbers in percentages

3 Recently

	Dec 2021	Mar 2022	Jun 2022	Sep 2022	Dec 2022	Mar 2023	Jun 2023	Sep 2023	Dec 2023	Mar 2024	Jun 2024	Sep 2024
	70.00%	70.00%	70.00%	70.00%	62.98%	62.98%	62.98%	63.24%	63.24%	63.24%	63.24%	63.78%
	13.02%	12.22%	12.04%	1.67%	0.10%	0.10%	0.10%	0.10%	0.07%	0.07%	0.07%	0.69%
	5.52%	5.23%	5.22%	0.55%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
	11.47%	12.55%	12.74%	27.78%	36.92%	36.91%	36.92%	36.67%	36.69%	36.69%	36.69%	35.53%
No. of Shareholders	15,471	26,123	26,114	63,911	62,007	58,560	55,569	52,255	49,600	45,996	43,813	41,986

	Mar 2021	Mar 2022	Mar 2023	Mar 2024	Sep 2024
	70.00%	70.00%	62.98%	63.24%	63.78%
	10.51%	12.22%	0.10%	0.07%	0.69%
	8.09%	5.23%	0.00%	0.00%	0.00%
	11.40%	12.55%	36.91%	36.69%	35.53%
No. of Shareholders	7,827	26,123	58,560	45,996	41,986

* The classifications might have changed from Sep'2022 onwards. The new XBRL format added more details from Sep'22 onwards.

Classifications such as banks and foreign portfolio investors were not available earlier. The sudden changes in FII or DII can be because of these changes.

Click on the line-items to see the names of individual entities.

Documents

Announcements

All

Annual reports

DRHP

Concalls

Oct 2024

Transcript

Notes
PPT
Aug 2024

Transcript

Notes
PPT
May 2024

Transcript

Notes
PPT
Feb 2024

Transcript

Notes
PPT
Nov 2023

Transcript

Notes
PPT
Aug 2023

Transcript

Notes
PPT